|
FY2021
12 months to Dec 31, 2021
|
FY2020
8 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income/(loss) | ||
| Adjustments to reconcile net income/(loss) to net cash used in operating activities: | ||
| Offering costs allocable to Outstanding Warrant liabilities | ||
| Change in fair value of Forward Purchase Agreement liabilities/assets | ||
| Change in fair value of Outstanding Warrant liabilities | ||
| Dividends earned on marketable securities held in Trust Account | ||
| Realized gains on marketable securities held in Trust Account | ||
| Change in unrealized gains on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Dividends receivable from operating account | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Income taxes payable | ||
| Due to related party | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Investment of cash in Trust Account | ||
| Cash withdrawn from Trust Account to pay income taxes | ||
| Net cash provided by/(used in) investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from sale of Sponsor and Director Warrants | ||
| Proceeds from promissory note – related party | ||
| Payment of offering costs | ||
| Proceeds from issuance of Class B Common Stock to Sponsor | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash and cash equivalents – beginning of period | ||
| Cash and cash equivalents – end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Cash paid for income taxes | ||
| Supplemental disclosure of non-cash activities: | ||
| Deferred underwriting fees payable | ||
| Initial classification of common stock subject to possible redemption | ||
| Change in value of common stock subject to possible redemption |
Loading...
